|
⚲
|
| Keyboard |
| Patel Naimish
✚
|
|
|---|---|
| CIK # | 0002021679 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002021679] | |
| 4 | [0002021679] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Patel Naimish | |
| CRISPR Therapeutics AG |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2026-03-20 | Grant | 38,499 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2026-03-20 | Grant | 30,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2026-03-16 | Sell | 3,150 | $48.26 | 152,019 |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2026-03-14 | Option exercise | 8,125 | ||
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2026-03-14 | Option exercise | 8,125 | ||
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2025-10-03 | Grant | 16,500 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2025-05-30 | Grant | 25,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2025-05-29 | Sell | 3,932 | $35.94 | 141,316 |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2025-05-28 | Option exercise | 10,000 | ||
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2025-05-28 | Option exercise | 10,000 | ||
|
CRISPR Therapeutics AG CRSP
Common Shares
|
2025-04-03 | Buy | 1,508 | $32.96 | 49,704 |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2025-03-14 | Grant | 32,500 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2025-03-14 | Grant | 46,667 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2024-10-16 | Grant | 18,333 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Stock Option (Right to Buy) · derivative
|
2024-05-28 | Grant | 85,000 | $0.00 | |
|
CRISPR Therapeutics AG CRSP
Restricted Stock Units · derivative
|
2024-05-28 | Grant | 40,000 | $0.00 |